These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Familial risk of Behçet's disease among first-degree relatives: a population-based aggregation study in Korea. Ahn HS; Kim HJ; Kazmi SZ; Kang T; Jun JB; Kang MJ; Kim KB; Kee SH; Kim DS; Hann HJ Rheumatology (Oxford); 2021 Jun; 60(6):2697-2705. PubMed ID: 33241295 [TBL] [Abstract][Full Text] [Related]
5. Clinical course of ocular Behçet's disease in siblings. Onal S; Tugal-Tutkun I; Urgancioglu M; Gul A Ocul Immunol Inflamm; 2001 Jun; 9(2):111-24. PubMed ID: 11449327 [TBL] [Abstract][Full Text] [Related]
6. Linkage mapping of a novel susceptibility locus for Behçet's disease to chromosome 6p22-23. Gül A; Hajeer AH; Worthington J; Ollier WE; Silman AJ Arthritis Rheum; 2001 Nov; 44(11):2693-6. PubMed ID: 11710725 [TBL] [Abstract][Full Text] [Related]
7. Close association of HLA-B51 and B52 in Israeli patients with Behçet's syndrome. Arber N; Klein T; Meiner Z; Pras E; Weinberger A Ann Rheum Dis; 1991 Jun; 50(6):351-3. PubMed ID: 2059078 [TBL] [Abstract][Full Text] [Related]
8. Mevalonate kinase gene mutations and their clinical correlations in Behçet's disease. Arslan Taş D; Erken E; Yildiz F; Dinkçi S; Sakalli H Int J Rheum Dis; 2014 May; 17(4):435-43. PubMed ID: 24411001 [TBL] [Abstract][Full Text] [Related]
10. The prevalence of Behçet's disease above the age of 10 years. The results of a pilot study conducted at the Park Primary Health Care Center in Ankara, Turkey. Idil A; Gürler A; Boyvat A; Caliskan D; Ozdemir O; Isik A; Tunçbilek A; Koçyigit P; Calikoglu E Ophthalmic Epidemiol; 2002 Dec; 9(5):325-31. PubMed ID: 12528917 [TBL] [Abstract][Full Text] [Related]
12. Familial aggregation in Behçet's disease: high frequency in siblings and parents of pediatric probands. Koné-Paut I; Geisler I; Wechsler B; Ozen S; Ozdogan H; Rozenbaum M; Touitou I J Pediatr; 1999 Jul; 135(1):89-93. PubMed ID: 10393610 [TBL] [Abstract][Full Text] [Related]
13. The prevalence of Behçet's disease in a city in Central Anatolia in Turkey. Çölgeçen E; Özyurt K; Ferahbaş A; Borlu M; Kulluk P; Öztürk A; Öner AÖ; Gün İ; Aşçıoğlu Ö Int J Dermatol; 2015 Mar; 54(3):286-9. PubMed ID: 25039755 [TBL] [Abstract][Full Text] [Related]
14. Tumour necrosis factor-alpha gene promoter region -308 and -376 G-->A polymorphisms in Behçet's disease. Duymaz-Tozkir J; Gül A; Uyar FA; Ozbek U; Saruhan-Direskeneli G Clin Exp Rheumatol; 2003; 21(4 Suppl 30):S15-8. PubMed ID: 14727453 [TBL] [Abstract][Full Text] [Related]
15. Sex-specific analysis in Behçet's disease reveals higher genetic risk in male patients. Jo YG; Ortiz-Fernández L; Coit P; Yilmaz V; Yentür SP; Alibaz-Oner F; Aksu K; Erken E; Düzgün N; Keser G; Cefle A; Yazici A; Ergen A; Alpsoy E; Salvarani C; Kısacık B; Kötter I; Henes J; Çınar M; Schaefer A; Nohutcu RM; Takeuchi F; Harihara S; Kaburaki T; Messedi M; Song YW; Kaşifoğlu T; Martin J; González Escribano MF; Saruhan-Direskeneli G; Direskeneli H; Sawalha AH J Autoimmun; 2022 Oct; 132():102882. PubMed ID: 35987173 [TBL] [Abstract][Full Text] [Related]
16. Clinical and Demographical Characteristics of Familial Behçet's Disease (Southeast Marmara Region). Ceylan Kalın Z; Sarıcaoğlu H; Yazici S; Aydoğan K; Bülbül Başkan E Dermatology; 2019; 235(5):407-412. PubMed ID: 31288224 [TBL] [Abstract][Full Text] [Related]